首页> 外文期刊>Infection and immunity >Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.
【24h】

Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.

机译:减毒的痘苗病毒-子孢子蛋白重组体可预防啮齿动物的疟疾。

获取原文
           

摘要

NYVAC-based vaccinia virus recombinants expressing the circumsporozoite protein (CSP) were evaluated in the Plasmodium berghei rodent malaria model system. Immunization of mice with a NYVAC-based CSP recombinant elicited a high level of protection (60 to 100%). Protection did not correlate with CS repeat-specific antibody responses and was abrogated by in vivo CD8+ T-cell depletion. Protection was not enhanced by modification of the subcellular localization of CSP. These results suggest the potential of poxvirus-based vectors for the development of vaccine candidates for human malaria.
机译:表达了环子孢子蛋白(CSP)的基于NYVAC的痘苗病毒重组体在伯氏疟原虫啮齿动物疟疾模型系统中进行了评估。使用基于NYVAC的CSP重组体对小鼠进行免疫可产生高水平的保护(60%至100%)。保护与CS重复特异性抗体反应无关,并通过体内CD8 + T细胞耗竭而被废除。通过修饰CSP的亚细胞定位不能增强保护作用。这些结果表明基于痘病毒的载体在开发人类疟疾候选疫苗方面的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号